Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.
Chemotherapy
Clinical practice guidelines
Irradiation
Recurrence
Surgery
Uterine cervical cancer
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
18
09
2018
accepted:
30
09
2018
pubmed:
7
10
2018
medline:
28
2
2019
entrez:
7
10
2018
Statut:
ppublish
Résumé
The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard treatment strategies for cervical cancer, indicating treatment methods currently considered appropriate for cervical cancer, minimizing variances in treatment methods among institutions, improving the safety of treatment and prognosis of diseases, reducing the economic and psychosomatic burden of patients by promoting performance of appropriate treatment, and enhancing mutual understanding between patients and healthcare professionals. The guidelines were prepared through consensus of the JSGO Guideline Committee, based on careful review of evidence gathered through the literature searches and in view of the medical health insurance system and actual clinical practice situations in Japan. The guidelines comprise eight chapters and five algorithms. The main features of the 2017 revision are as follows: (1) evidence was collected using a search formula and with cooperation of the Japan Library Association. The bibliographical search formula was placed at the end of the book; (2) regarding clinical questions (CQs) where evidence or clinical inspection in Japan was lacking, opinions of the Guidelines Committee were described as "proposals for future directions"; (3) cervical intraepithelial neoplasia (CIN) 3 and adenocarcinoma in situ (AIS) were treated as a cervical precancerous lesion; (4) the CQs of endoscopic surgery, radical trachelectomy, and sentinel node biopsy were newly added in Chapter 3, "primary treatment for stage IB-II cervical cancer"; and (5) the CQ about hormone replacement therapy after cancer treatment was newly established. Each recommendation is accompanied by a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSGO Guidelines 2017 for the Treatment of Uterine Cervical Cancer.
Identifiants
pubmed: 30291468
doi: 10.1007/s10147-018-1351-y
pii: 10.1007/s10147-018-1351-y
doi:
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-19Références
Cancer. 1999 Apr 1;85(7):1537-46
pubmed: 10193944
Int J Gynecol Cancer. 2000 Jul;10(4):305-312
pubmed: 11240691
Gynecol Oncol. 2001 Jul;82(1):11-6
pubmed: 11426955
Int J Gynecol Cancer. 1998 Jan;8(1):23-26
pubmed: 11576283
Int J Gynecol Cancer. 1993 Jul;3(4):193-198
pubmed: 11578344
Gan To Kagaku Ryoho. 2002 Jun;29(6):1047-54
pubmed: 12109445
Gan To Kagaku Ryoho. 2002 Jun;29(6):970-7
pubmed: 12109450
Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51
pubmed: 12519111
Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1354-60
pubmed: 12873680
Ann Oncol. 2003 Oct;14(10):1511-7
pubmed: 14504051
Eur J Gynaecol Oncol. 2004;25(1):81-6
pubmed: 15053068
Br J Cancer. 2004 Sep 13;91(6):1032-7
pubmed: 15292935
Gynecol Oncol. 2004 Oct;95(1):70-6
pubmed: 15385112
Tohoku J Exp Med. 2004 Nov;204(3):221-8
pubmed: 15502422
Gynecol Oncol. 2005 Mar;96(3):665-70
pubmed: 15721409
Gan To Kagaku Ryoho. 1992 May;19(5):695-701
pubmed: 1580643
Gan To Kagaku Ryoho. 1992 Jun;19(6):885-92
pubmed: 1605666
Radiat Med. 2005 Aug;23(5):327-30
pubmed: 16342904
Int J Gynecol Cancer. 2006 Jan-Feb;16(1):294-7
pubmed: 16445648
Semin Radiat Oncol. 2006 Jul;16(3):144-51
pubmed: 16814154
Gynecol Oncol. 2007 May;105(2):299-303
pubmed: 17303230
Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1438-44
pubmed: 17394944
Cancer. 2007 Dec 15;110(12):2716-25
pubmed: 17960806
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):428-34
pubmed: 18037584
Acta Oncol. 2008;47(3):434-41
pubmed: 18348003
Psychooncology. 2009 May;18(5):476-82
pubmed: 18702067
Int J Gynecol Cancer. 2009 Jan;19(1):21-6
pubmed: 19258936
J Clin Oncol. 1991 Nov;9(11):1956-61
pubmed: 1941053
Gynecol Oncol. 2009 Sep;114(3):528-35
pubmed: 19560188
J Clin Oncol. 2009 Oct 1;27(28):4649-55
pubmed: 19720909
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):751-7
pubmed: 19836154
Jpn J Clin Oncol. 2010 May;40(5):456-63
pubmed: 20133334
Int J Clin Oncol. 2010 Apr;15(2):117-24
pubmed: 20333431
Cancer. 2011 May 1;117(9):1928-34
pubmed: 21509770
Am J Obstet Gynecol. 2011 Jun;204(6):466-78
pubmed: 21752752
Gynecol Oncol. 1990 Sep;38(3):352-7
pubmed: 2227547
Lancet. 2012 Feb 11;379(9815):558-69
pubmed: 22325661
Gynecol Oncol. 2012 Aug;126(2):211-6
pubmed: 22555110
Gynecol Oncol. 2012 Sep;126(3):341-5
pubmed: 22609108
Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008217
pubmed: 23543561
Cochrane Database Syst Rev. 2013 Nov 25;(11):CD008767
pubmed: 24277645
Pract Radiat Oncol. 2013 Apr-Jun;3(2):115-23
pubmed: 24674314
PLoS One. 2014 Apr 18;9(4):e94116
pubmed: 24748015
Anticancer Res. 2014 Sep;34(9):5091-8
pubmed: 25202097
J Clin Oncol. 2015 Jul 1;33(19):2129-35
pubmed: 25732161
Int J Clin Oncol. 2015 Apr;20(2):240-8
pubmed: 25800808
J Gynecol Oncol. 2015 Apr;26(2):90-9
pubmed: 25872890
Radiother Oncol. 1988 Feb;11(2):101-12
pubmed: 3281186
CA Cancer J Clin. 1983 Jul-Aug;33(4):194-214
pubmed: 6407725
JAMA. 1995 Aug 2;274(5):387-93
pubmed: 7616634
Cancer. 1995 Nov 15;76(10 Suppl):1978-86
pubmed: 8634988
Obstet Gynecol. 1996 Aug;88(2):274-9
pubmed: 8692515
Gynecol Oncol. 1997 Nov;67(2):154-61
pubmed: 9367699
Gynecol Oncol. 1998 Mar;68(3):220-5
pubmed: 9570969
Cancer. 1998 Jun 1;82(11):2241-8
pubmed: 9610705